Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Pharmaceutical Division	87.60B	71.32B	51.56B	47.09B	14.59B
Pharmaceutical Division Growth	22.83%	38.31%	9.50%	222.85%	-
Unallocated Adjustment	-	-	-	-68.45M	-
Cosmetics Division	-	-	-	2.15B	841.33M
Cosmetics Division Growth	-	-	-	155.96%	-
Mining Division	-	-	-	8.39B	28.16B
Mining Division Growth	-	-	-	-70.23%	-
Total	87.60B	71.32B	51.56B	57.56B	43.59B
Total Growth	22.83%	38.31%	-10.42%	32.04%	-3.03%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Korea	85.34B	69.79B	48.26B	52.33B	19.60B
Korea Growth	22.28%	44.62%	-7.79%	167.04%	111.43%
Japan	400.76M	264.12M	77.82M	2.06B	21.35B
Japan Growth	51.73%	239.40%	-96.23%	-90.33%	-26.66%
People's Republic of China	631.75M	886.35M	921.12M	879.14M	1.93B
People's Republic of China Growth	-28.72%	-3.78%	4.78%	-54.49%	-66.33%
Russia	185.15M	277.09M	213.40M	419.11M	-
Russia Growth	-33.18%	29.84%	-49.08%	-	-
Other	1.07B	1.23B	2.08B	1.86B	482.31M
Other Growth	-12.82%	-41.10%	11.83%	286.18%	85.68%
Vietnam	-	149.27M	13.55M	263.00K	228.90M
Vietnam Growth	-	1001.45%	5052.85%	-99.89%	-60.29%
Total	87.63B	72.59B	51.56B	57.56B	43.59B
Total Growth	20.71%	40.78%	-10.42%	32.04%	-3.03%

Source: S&P Global Market Intelligence.